STINE HOLE

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Aromatase inhibitor (AI) treatment is first-line systemic treatment for the majority of postmenopausal breast cancer patients with estrogen receptor (ER)-positive primary tumor. Although many patients benefit from treatment, some will develop resistance, and models mimicking acquired resistance will be valuable tools to unravel the resistance mechanisms and(More)
  • 1